Latest News
Prospect Capital Shares Slide on Earnings Miss and Dividend Cut
Prospect Capital shares dropped 9.6% after Q1 net investment income fell to $78.5 million and the company cut its monthly dividend to $0.035 per share.
DXC Technology Shares Tumble 23% on Weak Revenue Outlook and AI Turnaround Doubts
DXC Technology shares fell 23% after forecasting further organic revenue declines and reporting a GAAP loss, casting doubt on its AI-driven turnaround amid weak demand.
Main Street Capital Shares Slide on Q1 Earnings Miss Amid Dividend Coverage Concerns
Main Street Capital shares fell 4.5% after Q1 earnings missed estimates, raising questions about dividend sustainability amid credit quality concerns.
Moderna Jumps 10% on Hantavirus Vaccine Push as Cruise Ship Outbreak Revives mRNA Hopes
Moderna shares rose 10% on Friday after the company revealed early-stage work on a hantavirus vaccine, spurred by a deadly Andes virus outbreak on the MV Hondius cruise ship.
Wynn Resorts Shares Slide on UAE Delay and $900M Macau Expansion
Wynn Resorts stock dropped 6.7% Friday despite beating Q1 profit estimates, as a delayed UAE opening and a $900M+ Macau expansion raised capital concerns.
MaxLinear Stock Surges Past $100 on AI Data Center Demand Ahead of Key Vote
MaxLinear shares surged over 21% to $101.20, driven by AI demand. A shareholder vote on expanding the equity plan is set for May 20.
Arbor Realty Trust Plunges After Dividend Cut and Weak Q1 Results
Arbor Realty Trust cut its dividend to $0.17 and reported Q1 net income of just $629,000, sending shares down 11% as investors focus on troubled loans.
Novavax Shares Surge on Pfizer Deal, Vaccine Strategy Shift
Novavax shares surged 13% Friday after Q1 revenue of $139.5 million beat estimates, fueled by a $30 million Pfizer licensing deal for Matrix-M adjuvant.
POET Technologies Stock Rebounds Amid Securities Lawsuit and Marvell Fallout
POET Technologies shares rebounded 14.5% to $10.97 on Friday, even as a securities lawsuit over tax disclosures and cancelled Celestial AI orders moves forward with a June 29 lead plaintiff deadline.
nLIGHT Soars on Record Defense Revenue, 55% Sales Jump
nLIGHT shares surged 10.3% after Q1 revenue jumped 55% to $80.2M, driven by record aerospace and defense sales, with the company swinging to a profit and launching its HADES laser system.
Traws Pharma Soars on Hantavirus Push After Cruise Fatalities
Traws Pharma shares surged over 21% after the biotech said it would advance hantavirus drug candidates following a fatal cruise ship outbreak. The company has no approved treatments and recently raised $10 million.